Mohs microscopic surgery and image-guided superficial radiation therapy (IG-SRT) demonstrate high cure rates for non-melanoma ...

Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...

A team of researchers have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks. This study, conducted by researchers from the Andalusian ...

A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University ...

Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression ...

After James Van Der Beek shared that he was auctioning his treasures to pay for cancer treatment, Paul Walter Hauser ...

Marginal zone lymphoma treatment evolves with promising CAR T-cell therapies, addressing unmet needs in aggressive cases and improving patient outcomes.

A healthy 8-year-old boy presented to our dermatology clinic with a 4-week history of worsening movement limitation and pain due to skin retraction of the right axilla. There were no constitutional ...

Patients with early-stage Hodgkin lymphoma had impressive response rates when treated with a novel combination of ...